| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 104,081 | 29,386 | | Cost of Revenue | 41,077 | 14,385 | | | Gross Profit | 63,003 | 15,000 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 20,126 | 5,099 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 42,877 | 9,902 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,629 | 410 | | Earnings Before Interest And Taxes | 46,506 | 9,050 | | Interest Expense |
-
|
-
| | Income Before Tax | 46,506 | 9,050 | | Income Tax Expense | (212) | (332) | | Minority Interest | 91 | 11 | | | | Net Income From Continuing Ops | 46,810 | 9,393 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 46,810 | 9,393 | | Preferred Stock And Other Adjustments |
-
| (6,625) | | | Net Income Applicable To Common Shares | $46,810 | $2,768 |
|
0.20% Nasdaq 
Income Statement
